ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $168,000 | -26.6% | 21,600 | -14.3% | 0.00% | -50.0% |
| Q3 2021 | $229,000 | +53.7% | 25,200 | +152.0% | 0.01% | +100.0% |
| Q4 2020 | $149,000 | +40.6% | 10,000 | -45.1% | 0.00% | -33.3% |
| Q2 2020 | $106,000 | -85.8% | 18,200 | -48.8% | 0.01% | -88.0% |
| Q1 2020 | $748,000 | +165.2% | 35,566 | +159.6% | 0.05% | +233.3% |
| Q4 2019 | $282,000 | -58.7% | 13,700 | -90.9% | 0.02% | -73.2% |
| Q3 2019 | $683,000 | +5.9% | 150,500 | -0.3% | 0.06% | +12.0% |
| Q2 2019 | $645,000 | +73.4% | 151,000 | -40.5% | 0.05% | +51.5% |
| Q1 2019 | $372,000 | – | 253,700 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |